Geode Capital Management’s ProPhase Labs PRPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-16,262
| Closed | -$7.28K | – | 4577 |
|
|
2025
Q4 | $7.28K | Sell |
16,262
-14,031
| -46% | -$39.5K | ﹤0.01% | 4444 |
|
|
2025
Q3 | $139K | Buy |
30,293
+4,387
| +17% | +$17K | ﹤0.01% | 4040 |
|
|
2025
Q2 | $101K | Buy |
25,906
+3,137
| +14% | +$10.5K | ﹤0.01% | 4056 |
|
|
2025
Q1 | $92.1K | Buy |
22,769
+2,416
| +12% | +$11.1K | ﹤0.01% | 4054 |
|
|
2024
Q4 | $154K | Buy |
20,353
+4,279
| +27% | +$60K | ﹤0.01% | 3974 |
|
|
2024
Q3 | $389K | Buy |
16,074
+1,359
| +9% | +$38.3K | ﹤0.01% | 3691 |
|
|
2024
Q2 | $615K | Buy |
14,715
+874
| +6% | +$45.8K | ﹤0.01% | 3492 |
|
|
2024
Q1 | $896K | Buy |
13,841
+100
| +0.7% | +$5.07K | ﹤0.01% | 3406 |
|
|
2023
Q4 | $621K | Buy |
13,741
+1,041
| +8% | +$47.5K | ﹤0.01% | 3534 |
|
|
2023
Q3 | $555K | Sell |
12,700
-614
| -5% | -$36K | ﹤0.01% | 3562 |
|
|
2023
Q2 | $967K | Buy |
13,314
+1,011
| +8% | +$82.3K | ﹤0.01% | 3376 |
|
|
2023
Q1 | $937K | Hold |
12,303
| – | – | ﹤0.01% | 3378 |
|
|
2022
Q4 | $1.18M | Buy |
12,303
+668
| +6% | +$72.2K | ﹤0.01% | 3271 |
|
|
2022
Q3 | $1.31M | Buy |
11,635
+454
| +4% | +$52.8K | ﹤0.01% | 3260 |
|
|
2022
Q2 | $1.42M | Buy |
11,181
+595
| +6% | +$52.3K | ﹤0.01% | 3259 |
|
|
2022
Q1 | $740K | Hold |
10,586
| – | – | ﹤0.01% | 3752 |
|
|
2021
Q4 | $758K | Hold |
10,586
| – | – | ﹤0.01% | 3842 |
|
|
2021
Q3 | $550K | Buy |
10,586
+315
| +3% | +$18.8K | ﹤0.01% | 3988 |
|
|
2021
Q2 | $636K | Buy |
10,271
+2,163
| +27% | +$121K | ﹤0.01% | 3824 |
|
|
2021
Q1 | $599K | Buy |
8,108
+5,442
| +204% | +$522K | ﹤0.01% | 3744 |
|
|
2020
Q4 | $244K | Buy |
+2,666
| New | +$223K | ﹤0.01% | 3824 |
|
Other funds holding PRPH
Geode Capital Management's PRPH Position: Q1 2026 in Review
Geode Capital Management sold out of ProPhase Labs (PRPH) in Q1 2026, closing a stake of 16,262 shares — an estimated $7.28K sold.
Geode Capital Management first reported a position in PRPH in Q4 2020 and held it in 21 quarters. The position peaked at $1.42M in Q2 2022. 2 funds tracked by Wall St. Rank hold PRPH as of Q1 2026.
- Geode Capital Management reported no remaining ProPhase Labs position as of Q1 2026 after selling out during the quarter.
- Geode Capital Management sold 16,262 ProPhase Labs shares in Q1 2026, an estimated $7.28K.
- Geode Capital Management first reported a position in ProPhase Labs in Q4 2020 and held it in 21 quarters.
- Geode Capital Management's ProPhase Labs position peaked at $1.42M in Q2 2022.
- 2 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.